Patents by Inventor Grégorie Prevost

Grégorie Prevost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug
    Patent number: 8710091
    Abstract: The present application relates to novel imidazolidine-2,4-dione derivatives of the general formula (I), where R1, R2, R3, R4, X, and Y are variables. Said materials have an antiproliferative activity. They are particularly useful for treating pathological conditions and diseases, such as cancer, that are linked to abnormal cell proliferation. The invention also relates to pharmaceutical compositions containing said materials and to the use thereof for preparing a drug.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: April 29, 2014
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Grégorie Prevost, Serge Auvin, Christophe Lanco, Anne-Marie Liberatore, Olivier Lavergne
  • TRIAMINOPYRIMIDINE CYCLOBUTENEDIONE DERIVATIVES USED AS PHOSPHATASE CDC25 INHIBITORS
    Publication number: 20100173910
    Abstract: The present invention relates to triaminopyrimidine derivatives of formula (I) where Y, R3, W, R4a, R5a, R4b, R5b, n and m are variable. These compounds have CDC25 phosphatase-inhibiting activity and can therefore be used as drugs in diseases in which CDC25 phosphatases are involved. The invention also relates to pharmaceutical compositions containing said products and methods of using the drug.
    Type: Application
    Filed: July 10, 2008
    Publication date: July 8, 2010
    Applicant: IPDRN PHSTMS D.S.S.
    Inventors: Anne-Marie Liberatore, Dominique Pons, Dennis Bigg, Grégorie Prevost, Marie-Christine Brezak Pannetier
  • TRIAMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF CDC25 PHOSPHATASE
    Publication number: 20100137275
    Abstract: The present invention relates to the novel triaminopyrimidine derivatives of formula (I) in which R1, R2, W, R3, R4, and R5 are variable groups. These products have a Cdc25-phosphatase-inhibiting activity. The invention also relates to a process for synthesizing these compounds and also to therapeutic compositions containing these products and to the use thereof as medicaments.
    Type: Application
    Filed: April 30, 2008
    Publication date: June 3, 2010
    Applicant: IPSEN PHARMA S.A.S.
    Inventors: Grégorie Prevost, Anne-Marie Liberatore, Dennis Bigg, Dominique Pons